bii_horizontal_logo_small
More

RESEARCH DATA INTEGRATION

Research

Data science is an important component of biomedical and translational research, where data of multiple modalities are being constantly generated at unprecedented scale. The Research Data Integration group in the Biomedical Datahub Division aims to bridge the complexity of computational biology and data science with the needs of biologists and clinicians to drive biological discoveries and predict translational outcomes. To achieve this goal, we are developing capabilities to analyze and integrate multi-omics, imaging and clinical data generated by biomedical institutes, hospitals and national platforms in Singapore to improve the usability and interpretability of large-scale multimodal datasets of cancer and other diseases. 

Cancer is one of our disease focus in the Biomedical Datahub. Our group uses a wide range of computational, statistical and machine learning approaches and annotation databases to analyze large-scale multi-modal datasets generated from cancer patients, xenografts, organoids and cell lines. We work closely with cancer biologists, bioinformaticians and clinicians to build clinical and experimental cancer data resources that can drive research analysis and inform treatment options in the clinic, thereby improving patient outcomes
BDHD-RDI-Fig1

Members

 Senior Principal Investigator WOO Xing Yi   |    [View Bio]  

 



Woo Xing Yi

close
BII_Woo Xing Yi WOO Xing Yi 
Senior Principal Investigator
Email: woo_xing_yi@bii.a-star.edu.sg
Research Group: Research Data Integration

Xing Yi Woo obtained her PhD in Chemical Engineering from the Joint-PhD program of University of Illinois at Urbana Champaign and National University of Singapore. She did her postdoctoral fellowship in the Genome Institute of Singapore under the mentorship of Professors Edison Liu and Guillaume Bourque. Subsequently, she joined The Jackson Laboratory as a computational scientist and made significant contributions in a wide range of computational projects, including analysis pipeline development, clinical curation and downstream analysis of large-scale datasets of cancer and patient-derived xenografts. She has led analysis projects in cancer resources and consortiums, and contributed to publications in high impact journals, including Nature Genetics, Proceedings of the National Academy of Sciences, Cancer Research and Genome Research.

Group Member

Senior Principal Investigator WOO Xing Yi 

 

Selected Publications

  • Katrin P Guillen, Maihi Fujita, Andrew J Butterfield, Sandra D Scherer, Matthew H Bailey, Zhengtao Chu, Yoko S DeRose, Ling Zhao, Emilio Cortes-Sanchez, Chieh-Hsiang Yang, Jennifer Toner, Guoying Wang, Yi Qiao, Xiaomeng Huang, Jeffery A Greenland, Jeffery M Vahrenkamp, David H Lum, Rachel E Factor, Edward W Nelson, Cindy B Matsen, Jane M Poretta, Regina Rosenthal, Anna C Beck, Saundra S Buys, Christos Vaklavas, John H Ward, Randy L Jensen, Kevin B Jones, Zheqi Li, Steffi Oesterreich, Lacey E Dobrolecki, Satya S Pathi, Xing Yi Woo, Kristofer C Berrett, Mark E Wadsworth, Jeffrey H Chuang, Michael T Lewis, Gabor T Marth, Jason Gertz, Katherine E Varley, Bryan E Welm, Alana L Welm. A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology. Nature Cancer 3, 232–250 (2022). https://doi.org/10.1038/s43018-022-00337-6

  • Hua Sun, Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael Wendl, Sherri Davies, Matthew Bailey, Tina Primeau, Jeremy Hoog, Jacqueline Mudd, Dennis Dean,II, Rajesh Patidar, Lily Chen, Matthew Wyczalkowski, Reyka Jayasinghe, Fernanda Rodrigues, Nadezhda Terekhanova, Yize Li, Kian-Huat Lim, Andrea Wang-Gillam, Brian Van Tine, Cynthia Ma, Rebecca Aft, Katherine Fuh, Julie Schwarz, Jose Zevallos, Sidharth Puram, John DiPersio, The NCI PDXNet Consortium, Brandi Davis-Dusenbery, Matthew Ellis, Michael Lewis, Michael Davies, Meenhard Herlyn, Bingliang Fang, Jack Roth, Alana L Welm, Bryan Welm, Funda Meric-Bernstam, Feng Chen, Ryan Fields, Shunqiang Li, Ramaswamy Govindan, James Doroshow, Jeffrey Moscow, Yvonne Evrard, Jeffrey Chuang, Benjamin Raphael, and Li Ding. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.  Nature Communications 12, 5086 (2021). https://doi.org/10.1038/s41467-021-25177-3

  • Xing Yi Woo*, Jessica Giordano*, Anuj Srivastava, Zi-Ming Zhao, Michael W Lloyd, Roebi de Bruijn, Yun-Suhk Suh, Rajesh Patidar, Li Chen, Sandra Scherer, Matthew H Bailey, ChiehHsiang Yang, Emilio Cortes-Sanchez, Yuanxin Xi, Jing Wang, Jayamanna Wickramasinghe, Andrew V Kossenkov, Vito W Rebecca, Hua Sun, R Jay Mashl, Sherri R Davies, Ryan Jeon, Christian Frech, Jelena Randjelovic, Jacqueline Rosains, Francesco Galimi, Andrea Bertotti, Adam Lafferty, Alice C O’Farrell, Elodie Modave, Diether Lambrechts, Petra Ter Brugge, Violeta Serra, Elisabetta Marangoni, Rania El Botty, Hyunsoo Kim, Jong-Il Kim, Han-Kwang Yang, Charles Lee, Dennis A Dean, Brandi Davis-Dusenbery, Yvonne A Evrard, James H Doroshow, Alana L Welm, Bryan E Welm, Michael T Lewis, Bingliang Fang, Jack A Roth, Funda Meric-Bernstam, Meenhard Herlyn, Michael A Davies, Li Ding, Shunqiang Li, Ramaswamy Govindan, Claudio Isella, Jeffrey A Moscow, Livio Trusolino, Annette T Byrne, Jos Jonkers, Carol J Bult, Enzo Medico, Jeffrey H Chuang, PDXNET Consortium & EurOPDX Consortium. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.  Nature Genetics 53, 86–99 (2021). https://doi.org/10.1038/s41588-020- 00750-6

  • Yvonne A Evrard, Anuj Srivastava, Jelena Randjelovic, James H Doroshow, Dennis A Dean II, Jeffrey S Morris, Jeffrey H Chuang and The NCI PDXNet Consortium. Systematic establishment of robustness and standards in patient-derived xenograft experiments and analysis.  Cancer Research 80(11):2286-2297 (2020). DOI: 10.1158/0008-5472.CAN-19-3101

  • Xing Yi Woo*, Anuj Srivastava*, Joel H Graber*, Vinod Yadav, Vishal Kumar Sarsani, Al Simons, Glen Beane, Stephen Grubb, Guruprasad Ananda, Rangjiao Liu, Grace Stafford, Jeffrey H Chuang, Susan D Airhart, R Krishna Murthy Karuturi, Joshy George, Carol J Bult. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.  BMC Medical Genomics 12(1):92 (2019). https://doi.org/10.1186/s12920-019-0551-2

  • Francesca Menghi, Koichiro Inaki, Xing Yi Woo, Pooja A Kumar, Krzysztof R Grzeda, Ankit Malhotra, Vinod Yadav, Hyunsoo Kim, Eladio J Marquez, Duygu Ucar, Phung T Shreckengast, Joel P Wagner, George MacIntyre, Krishna R Murthy Karuturi, Ralph Scully, James Keck, Jeffrey H Chuang, Edison T Liu. The tandem duplicator phenotype as a distinct genomic configuration in cancer.  Proceedings of the National Academy of Sciences 113(17): E2373-E2382 (2016). DOI: 10.1073/pnas.1520010113

  • Koichiro Inaki*, Francesca Menghi*, Xing Yi Woo*, Joel P Wagner, Pierre-Étienne Jacques, Yi Fang Lee, Phung Trang Shreckengast, Wendy WeiJia Soon, Ankit Malhotra, Audrey SM Teo, Axel M Hillmer, Alexis Jiaying Khng, Xiaoan Ruan, Swee Hoe Ong, Denis Bertrand, Niranjan Nagarajan, R Krishna Murthy Karuturi, Alfredo Hidalgo Miranda, Edison T Liu. Systems consequences of amplicon formation in human breast cancer.  Genome research 24(10): 1559-1571 (2014). DOI: 10.1101/gr.164871.113

PSTA 2022 Call for Nominations

We are searching for individuals who dare push the boundaries of science and technology.

If you know of brilliant minds in your midst, nominate them now for the nation’s highest honour in Science and Technology – The President’s Science and Technology Awards 2022.

Nominations close on 17 May 2022.

Nominate NowView 2021 Winners